Abstract:BACKGROUND:Alzheimer's disease (AD) is the most common form of dementia, characterized by progressive cognitive impairment and neurodegeneration. However, despite extensive clinical and genomic studies, the molecular basis of AD development and progression remains elusive.METHODS:To elucidate molecular systems associated with AD, we developed a large scale gene expression dataset from 1053 postmortem brain samples across 19 cortical regions of 125 individuals with a severity spectrum of dementia and neuropathology of AD. We excluded brain specimens that evidenced neuropathology other than that characteristic of AD. For the first time, we performed a pan-cortical brain region genomic analysis, characterizing the gene expression changes associated with a measure of dementia severity and multiple measures of the severity of neuropathological lesions associated with AD (neuritic plaques and neurofibrillary tangles) and constructing region-specific co-expression networks. We rank-ordered 44,692 gene probesets, 1558 co-expressed gene modules and 19 brain regions based upon their association with the disease traits.RESULTS:The neurobiological pathways identified through these analyses included actin cytoskeleton, axon guidance, and nervous system development. Using public human brain single-cell RNA-sequencing data, we computed brain cell type-specific marker genes for human and determined that many of the abnormally expressed gene signatures and network modules were specific to oligodendrocytes, astrocytes, and neurons. Analysis based on disease severity suggested that: many of the gene expression changes, including those of oligodendrocytes, occurred early in the progression of disease, making them potential translational/treatment development targets and unlikely to be mere bystander result of degeneration; several modules were closely linked to cognitive compromise with lesser association with traditional measures of neuropathology. The brain regional analyses identified temporal lobe gyri as sites associated with the greatest and earliest gene expression abnormalities.CONCLUSIONS:This transcriptomic network analysis of 19 brain regions provides a comprehensive assessment of the critical molecular pathways associated with AD pathology and offers new insights into molecular mechanisms underlying selective regional vulnerability to AD at different stages of the progression of cognitive compromise and development of the canonical neuropathological lesions of AD.

SYSTEMS MODELING OF WHITE MATTER MICROSTRUCTURAL ABNORMALITIES IN ALZHEIMER’S DISEASE

Characterization of Local White Matter Microstructural Alterations in Alzheimer’s Disease: A Reproducible Study

DIFFERENTIAL GREY AND WHITE MATTER MICROSTRUCTURAL ABNORMALITIES IN EARLY AND LATE-ONSET ALZHEIMER’S DISEASE AND MILD COGNITIVE IMPAIRMENT

Associations of Alzheimer's Disease Pathology and Small Vessel Disease with Cerebral White Matter Degeneration: A Tract-Based MR Diffusion Imaging Study.

Transcriptomic, Cellular, and Functional Signatures of White Matter Damage in Alzheimer’s Disease

Temporal Alterations in White Matter in An App Knock-In Mouse Model of Alzheimers Disease

Data‐driven approach reveals heterogeneity and region‐specific association of white matter hyperintensities with the APOE genotype

Multivariate Analysis of White Matter Structural Networks of Alzheimer's Disease

Reproducible Abnormalities and Diagnostic Generalizability of White Matter in Alzheimer’s Disease

Gray matter structural covariance networks changes along the Alzheimer's disease continuum.

Multimodal Voxel-Based Meta-Analysis of White Matter Abnormalities in Alzheimer's Disease.

Uncovering the System Vulnerability and Criticality of Human Brain under Dynamical Neuropathological Events in Alzheimer's Disease

Abnormal white matter changes in Alzheimer's disease based on diffusion tensor imaging: A systematic review

Connectome-wide network analysis of white matter connectivity in Alzheimer's disease.

Molecular profiling of frontal and occipital subcortical white matter hyperintensities in Alzheimer's disease

Aberrant White Matter Microstructure as a Potential Diagnostic Marker in Alzheimer’s Disease by Automated Fiber Quantification

Integrative Network Analysis of Nineteen Brain Regions Identifies Molecular Signatures and Networks Underlying Selective Regional Vulnerability to Alzheimer’s Disease

Multilevel Deficiency of White Matter Connectivity Networks in Alzheimer’s Disease: A Diffusion MRI Study with DTI and HARDI Models

White matter integrity linked to functional impairments in aging and early Alzheimer's disease.

White matter integrity and key structures affected in Alzheimer's disease characterized by diffusion tensor imaging

Cognition-related White Matter Integrity Dysfunction in Alzheimer's Disease with Diffusion Tensor Image.